Compared with controls, IBD patients displayed significantly increased frequencies of IL-17A+IFN-gamma− cells and a marginal increase in IL17A+IFN-gamma+ cells, while the IL17A−IFN-gamma+ fraction was reduced significantly (Figure 7B). The gene discussed is IL17A; the disease is inflammatory bowel disease.